Sanofi prostate cancer drug Jevtana approved in Europe | InPharm

Links shared publicly online about this topic.

  • 423
    total visits

Sanofi prostate cancer drug Jevtana approved in Europe | InPharm

inpharm.com

Jevtana (cabazitaxel) approved in combination with the steroid prednisone by the European Commission to treat advanced second-line prostate cancer

View full resource at inpharm.com

Tags: Cancer, Cancer Medication, Prostate Cancer, Prostate Cancer Medication, Prostate, Drug, Men's Health, Sanofi-Aventis

  • Share

Most Recently Shared on March 21, 2011 at 11:53 am By:

Pharmafocus Pharmafocus

Sanofi prostate cancer drug Jevtana approved in Europe http://goo.gl/fb/AAPJM

1 year ago...

Sanofi launches Jevtana in UK | InPharm

inpharm.com — “Sanofi has launched its promising advanced prostate cancer drug Jevtana in the UK following EMA approval in MarchView full resource at inpharm.com

  • View Related
  • Share

Most Recently Shared on July 6, 2011 at 1:55 pm By:

Sanofi prostate cancer drug Jevtana approved in Europe | InPharm

inpharm.com — “Jevtana (cabazitaxel) approved in combination with the steroid prednisone by the European Commission to treat advanced second-line prostate cancerView full resource at inpharm.com

  • View Related
  • Share

Most Recently Shared on March 21, 2011 at 11:03 am By:

prostatecancer_ Prostate Cancer Support

Sanofi prostate cancer drug Jevtana approved in Europe http://bit.ly/e3bh6A

1 year ago...

Advertisement